Ignite Creation Date:
2025-12-24 @ 4:27 PM
Ignite Modification Date:
2026-02-17 @ 11:36 PM
Study NCT ID:
NCT02883166
Status:
COMPLETED
Last Update Posted:
2020-12-07
First Post:
2016-08-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Improving Bio-availability of the Expensive Oral Oncolytic Drug Abiraterone by Food Intake
Sponsor:
Radboud University Medical Center
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
UMCN-AKF-16.04
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None